Alnylam Pharmaceuticals | Passività Correnti





Passività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
BioCryst Pharmaceuticals USD 190.24M 13.08M 2025-09
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Incyte USD 1.52B 176.44M 2025-12
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
Moderna USD 1.99B 306M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novartis USD 32B 286M 2025-09
PTC Therapeutics USD 968.43M 102.18M 2025-12
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 28.35B 9.32B 2025-12
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
Takeda JPY 2.61T 470.53B 2025-12
Tectonic Therapeutic USD 9.37M 1.99M 2025-09
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Xencor USD 86.48M 9.6M 2025-09


Alnylam Pharmaceuticals Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.